Novocure’s tumor-treating electric fields fall short in ovarian cancer trial

NovoCure’s tumor treating fields (TTFields) failed to recreate its efficacy in previous cancer studies, after the company announced that the therapy did not meet its primary endpoint of overall survival in an ovarian cancer study.